Krista R Wooller1,2, Dominique Yelle1,2, Stacy Fisher3, Ian Carrigan4, Erin Kelly5. 1. Division of General Medicine, Department of Medicine, University of Ottawa; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. 2. co-first authors. 3. Ottawa Hospital Research Institute, Ottawa, Ontario, School of Epidemiology and Public Health, University of Ottawa, Ontario, Canada. 4. University of Ottawa Faculty of Medicine, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. 5. Division of Gastroenterology, Department of Medicine, University of Ottawa; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Abstract
Background: Quality indicators (QIs) exist for the care of patients with cirrhosis. We retrospectively examined the records of patients admitted to a large academic tertiary care centre for adherence to QIs and examined for an association between QI adherence and hospital outcomes. Methods: We conducted a cross-sectional study of all patients with decompensated liver cirrhosis admitted to a large academic tertiary care centre over a 2-year period (2014-2016). Medical records of 522 patients were examined for 17 QIs related to inpatient cirrhosis care and adherence-judged using three different standards: 100% adherence, 70% adherence, or the QI score as a continuous variable. Linear and logistic regression was used to evaluate the association between QI score and length of stay (LOS), 30-day readmissions, and inpatient mortality, respectively. Results: Adherence to QIs was variable (range 20%-95%). Overall, adherence to QIs relating to variceal bleeding was higher than adherence to indicators related to hepatic encephalopathy and spontaneous bacterial peritonitis. There was weak evidence for a decreased odds of 30-day readmission when more QIs were met, regardless of the method used to quantify adherence (100% standard OR 0.53 [95% CI 0.26-1.09, p = .09], 70% standard OR 0.58 [95% CI 0.32-1.06, p = .08], continuous method OR 0.90 [95% CI 0.81-1.01, p = .07]). There was no observed relationship between mortality and QI adherence and equivocal evidence for an association between QI adherence and LOS. Conclusions: Adherence to QIs related to inpatient care of decompensated cirrhosis may be associated with decreased 30-day readmissions.
Background: Quality indicators (QIs) exist for the care of patients with cirrhosis. We retrospectively examined the records of patients admitted to a large academic tertiary care centre for adherence to QIs and examined for an association between QI adherence and hospital outcomes. Methods: We conducted a cross-sectional study of all patients with decompensated liver cirrhosis admitted to a large academic tertiary care centre over a 2-year period (2014-2016). Medical records of 522 patients were examined for 17 QIs related to inpatient cirrhosis care and adherence-judged using three different standards: 100% adherence, 70% adherence, or the QI score as a continuous variable. Linear and logistic regression was used to evaluate the association between QI score and length of stay (LOS), 30-day readmissions, and inpatient mortality, respectively. Results: Adherence to QIs was variable (range 20%-95%). Overall, adherence to QIs relating to variceal bleeding was higher than adherence to indicators related to hepatic encephalopathy and spontaneous bacterial peritonitis. There was weak evidence for a decreased odds of 30-day readmission when more QIs were met, regardless of the method used to quantify adherence (100% standard OR 0.53 [95% CI 0.26-1.09, p = .09], 70% standard OR 0.58 [95% CI 0.32-1.06, p = .08], continuous method OR 0.90 [95% CI 0.81-1.01, p = .07]). There was no observed relationship between mortality and QI adherence and equivocal evidence for an association between QI adherence and LOS. Conclusions: Adherence to QIs related to inpatient care of decompensated cirrhosis may be associated with decreased 30-day readmissions.
Authors: Fasiha Kanwal; Jennifer Kramer; Steven M Asch; Hashem El-Serag; Brennan M R Spiegel; Steven Edmundowicz; Arun J Sanyal; Jason A Dominitz; Kenneth R McQuaid; Paul Martin; Emmet B Keeffe; Lawrence S Friedman; Samuel B Ho; Francisco Durazo; Bruce R Bacon Journal: Clin Gastroenterol Hepatol Date: 2010-04-10 Impact factor: 11.382
Authors: Fasiha Kanwal; Elliot B Tapper; Chanda Ho; Sumeet K Asrani; Nadia Ovchinsky; John Poterucha; Avegail Flores; Victor Ankoma-Sey; Bruce Luxon; Michael Volk Journal: Hepatology Date: 2019-03-12 Impact factor: 17.425
Authors: Fasiha Kanwal; Jennifer R Kramer; Paula Buchanan; Steven M Asch; Youssef Assioun; Bruce R Bacon; Juan Li; Hashem B El-Serag Journal: Gastroenterology Date: 2012-03-28 Impact factor: 22.682
Authors: Rony Ghaoui; Jennifer Friderici; Paul Visintainer; Peter K Lindenauer; Tara Lagu; David Desilets Journal: Liver Int Date: 2013-06-14 Impact factor: 5.828
Authors: Lindsay A Sobotka; Rohan M Modi; Akshay Vijayaraman; A James Hanje; Anthony J Michaels; Lanla F Conteh; Alice Hinton; Ashraf El-Hinnawi; Khalid Mumtaz Journal: World J Hepatol Date: 2018-06-27
Authors: David Reeves; Stephen M Campbell; John Adams; Paul G Shekelle; Evan Kontopantelis; Martin O Roland Journal: Med Care Date: 2007-06 Impact factor: 2.983